3/19
09:44 am
osrh
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
Low
Report
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
3/5
10:17 pm
osrh
OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum [Yahoo! Finance]
Low
Report
OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum [Yahoo! Finance]
2/2
10:02 am
osrh
CEO Statement to Shareholders [Yahoo! Finance]
High
Report
CEO Statement to Shareholders [Yahoo! Finance]
1/22
09:55 am
osrh
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
Medium
Report
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
1/16
09:32 am
osrh
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform [Yahoo! Finance]
Low
Report
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform [Yahoo! Finance]
1/16
09:20 am
osrh
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Medium
Report
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
1/12
08:05 am
osrh
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
Low
Report
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones